# ctDNA Monitoring in Early Breast Cancer

> **NCT04353557** · — · RECRUITING · sponsor: **Geneplus-Beijing Co. Ltd.** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04353557
- **Lead sponsor:** Geneplus-Beijing Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-11-29
- **Primary completion:** 2025-06
- **Final completion:** 2026-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04353557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04353557, "ctDNA Monitoring in Early Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04353557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*